Advertisement

Topics

Thermo Fisher’s Brammer Bio Completing $100M in Expansion Projects

08:00 EDT 14 Jun 2019 | Genetic Engineering News

Thermo Fisher Scientific's recently-acquired Brammer Bio is completing $100 million in capital expansion projects, as the viral vector CDMO looks to satisfy growing demand for gene therapies for clinical and commercial use.

The post Thermo Fisher’s Brammer Bio Completing $100M in Expansion Projects appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Thermo Fisher’s Brammer Bio Completing $100M in Expansion Projects

NEXT ARTICLE

More From BioPortfolio on "Thermo Fisher’s Brammer Bio Completing $100M in Expansion Projects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...